Vanguard Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.5B | Buy |
|
|||||
|
2025
Q2 | $14.7B | Buy |
|
|||||
|
2025
Q1 | $13.6B | Buy |
|
|||||
|
2024
Q4 | $11.9B | Buy |
|
|||||
|
2024
Q3 | $11B | Buy |
|
|||||
|
2024
Q2 | $10B | Buy |
|
|||||
|
2024
Q1 | $8.73B | Buy |
|
|||||
|
2023
Q4 | $7.25B | Buy |
|
|||||
|
2023
Q3 | $6.53B | Buy |
|
|||||
|
2023
Q2 | $6.61B | Buy |
|
|||||
|
2023
Q1 | $6.02B | Buy |
|
|||||
|
2022
Q4 | $5.5B | Buy |
|
|||||
|
2022
Q3 | $4.53B | Buy |
|
|||||
|
2022
Q2 | $4.29B | Buy |
|
|||||
|
2022
Q1 | $5.02B | Buy |
|
|||||
|
2021
Q4 | $4.74B | Buy |
|
|||||
|
2021
Q3 | $4.83B | Buy |
|
|||||
|
2021
Q2 | $4.71B | Buy |
|
|||||
|
2021
Q1 | $4.24B | Sell |
|
|||||
|
2020
Q4 | $3.98B | Sell |
|
|||||
|
2020
Q3 | $4.28B | Sell |
|
|||||
|
2020
Q2 | $3.97B | Buy |
|
|||||
|
2020
Q1 | $3.65B | Buy |
|
|||||
|
2019
Q4 | $4.93B | Buy |
|
|||||
|
2019
Q3 | $4.4B | Buy |
|
|||||
|
2019
Q2 | $4.59B | Buy |
|
|||||
|
2019
Q1 | $4.04B | Buy |
|
|||||
|
2018
Q4 | $3.67B | Buy |
|
|||||
|
2018
Q3 | $3.91B | Buy |
|
|||||
|
2018
Q2 | $3.27B | Buy |
|
|||||
|
2018
Q1 | $2.69B | Buy |
|
|||||
|
2017
Q4 | $2.4B | Buy |
|
|||||
|
2017
Q3 | $2.78B | Buy |
|
|||||
|
2017
Q2 | $2.6B | Buy |
|
|||||
|
2017
Q1 | $2.27B | Buy |
|
|||||
|
2016
Q4 | $1.9B | Buy |
|
|||||
|
2016
Q3 | $2.04B | Buy |
|
|||||
|
2016
Q2 | $1.93B | Sell |
|
|||||
|
2016
Q1 | $1.85B | Buy |
|
|||||
|
2015
Q4 | $1.75B | Buy |
|
|||||
|
2015
Q3 | $1.51B | Buy |
|
|||||
|
2015
Q2 | $1.59B | Sell |
|
|||||
|
2015
Q1 | $1.84B | Buy |
|
|||||
|
2014
Q4 | $1.35B | Buy |
|
|||||
|
2014
Q3 | $1.15B | Buy |
|
|||||
|
2014
Q2 | $1.22B | Buy |
|
|||||
|
2014
Q1 | $1.25B | Buy |
|
|||||
|
2013
Q4 | $1.08B | Buy |
|
|||||
|
2013
Q3 | $1.02B | Buy |
|
|||||
|
2013
Q2 | $784M | Buy |
|